The aseptic processing method is used to pack sterile drugs in sterile containers. This process is one of the most critical stages in biopharmaceutical manufacturing, because of the risk contamination poses to patient safety. An aseptic process simulation is performed by biopharmaceutical firms to ensure the process can be performed with minimal contamination. This is accomplished by using a growth medium instead of the actual product in the processing steps.
Regulators look for these aseptic processing simulations or media fills, as they are sometimes called, to demonstrate control of the process and also the operators executing the tasks. These simulations must be done periodically and with the knowledge of the regulations that govern them.
This session by expert speaker Danielle DeLucy will help those using APS/media fills to determine their risks of contamination in the process, and how they can prevent it. Danielle will give a complete review of what elements need to be included in the APS design, including the frequency of performance, the number of operators, what types of growth media to use, how slow or fast the filling line needs to operate, and how to read the units after they have been incubated.
This session will cover:
Who Should Attend
Ask a question at the Q&A session following the live event and get advice unique to your situation, directly from our expert speaker.
- Casper E. Uldriks
Danielle DeLucy, MS, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous...
More Events By The Speaker